A303810 logo

DK Life Science Co., Ltd. Stock Price

KOSDAQ:A303810 Community·₩110.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A303810 Share Price Performance

₩3,460.00
-1295.00 (-27.23%)
₩3,460.00
-1295.00 (-27.23%)
Price ₩3,460.00

A303810 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with adequate balance sheet.

1 Risk
2 Rewards

DK Life Science Co., Ltd. Key Details

₩130.3b

Revenue

₩97.4b

Cost of Revenue

₩33.0b

Gross Profit

₩24.3b

Other Expenses

₩8.7b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
270.70
25.31%
6.64%
27.9%
View Full Analysis

About A303810

Founded
2017
Employees
n/a
CEO
Jae Won Park
WebsiteView website
www.dkls.co.kr

DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally. It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments. The company also offers catheters, MRI, CT scanner, ultrasound, mobile CT scanner, and X-ray equipment, as well as mammography image analysis assistance software. DK Life Science Co., Ltd. was founded in 2017 and is based in Seoul, South Korea.

Recent A303810 News & Updates

Recent updates

No updates